CVS Health Corp., US1266501006

CVS Health stock heads into the open after a flat September 4, 2026 close

Published on 09/08/2026 at 06:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 4, 2026, CVS Health stock finished unchanged on the NYSE around its recent market cap level, with trading volume near its weekly average. Today, the stock enters a shortened week as investors watch broader healthcare and index cues.

Moderner Apothekenverkaufsraum mit Apothekerin und Kundin vor Medikamentenregalen
CVS Health Corp. zeigt fotorealen Apothekenverkaufsraum mit Apothekerin und Kundin, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock closed at USD 96.80 on the NYSE on September 4, 2026, effectively flat for the session with a daily change close to 0 percent according to exchange-based quote data referenced by market commentary.MarketBeat data The stock's recent pricing put CVS Health near a reported market capitalization of about USD 123.72 billion as of early September 2026, highlighting its scale relative to many healthcare peers.CompaniesMarketCap overview Today, the shares move into a shortened trading week in the United States after the Labor Day exchange holiday on September 7, 2026, with investors tracking sector sentiment and major index futures.

September 4, 2026 in numbers

CVS Health Corp. (ISIN US1266501006, NYSE: CVS) carried a closing price of USD 96.80 on September 4, 2026, which aligned with its intraday range reported for that day on primary quote services, indicating a relatively stable session in terms of volatility.MarketBeat data Market data placed the company's market capitalization around USD 123.72 billion as of early September 2026, and the flat close on September 4, 2026 suggested that investors largely maintained existing positions heading into the long weekend.CompaniesMarketCap overview Compared with broader United States equity benchmarks, which faced selling pressure around the same period, CVS Health's unchanged move for the last completed session meant the stock slightly outperformed indices that recorded negative returns into the holiday.CNBC market wrap

Analyst coverage cited by recent market commentary described CVS Health as carrying a moderate buy consensus rating and a consensus target price above the current share level, underscoring ongoing interest in the stock from research houses despite the quiet last session.MarketBeat data Separate coverage focusing on CVS Health's Aetna business highlighted efforts to improve profitability and execution, which remain part of the fundamental backdrop that many investors consider when evaluating the shares over a multi-session horizon.Zacks analysis on Yahoo Finance Together, these elements framed the September 4, 2026 session as a pause within a larger narrative around healthcare services performance and managed care profitability rather than a day driven by a single headline.

Today’s drivers for CVS Health

Today, CVS Health stock enters the first trading session after the September 7, 2026 Labor Day holiday, with United States exchanges resuming normal operations and investors returning from the long weekend.CBS News Labor Day schedule Company investor-relations and standard earnings calendars do not list a CVS Health quarterly or annual earnings release for September 8, 2026 within the immediate reporting cycle, so attention is likely to focus on broader healthcare sentiment, peer developments and regulatory news affecting insurers and pharmacy-benefit managers. In the wider market context, futures tied to major United States indices and recent commentary about equity flows and sector rotation provide additional cues that can influence trading in large healthcare names such as CVS Health as the shortened week begins.CNBC market wrap

Disclaimer...

en | US1266501006 | CVS HEALTH CORP. | boerse | 70066563 | bgmi